Antioxidant and acetylcholinesterase inhibitory activities of ginger root ( Zingiber officinale Roscoe) extract
Authors:
- 4 May 2017
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 14 (4)
Abstract
Background: Zingiber officinale Roscoe has been used in traditional medicine for the treatment of neurological disorder. This study aimed to investigate the phenolic contents, antioxidant, acetylcholinesterase enzyme (AChE) inhibitory activities of different fraction of Z. officinale root grown in Vietnam. Methods: The roots of Z. officinale are extracted with ethanol 96 % and fractionated with n-hexane, ethyl acetate (EtOAc) and butanol (BuOH) solvents. These fractions evaluated the antioxidant activity by 1,1-Diphenyl -2-picrylhydrazyl (DPPH) assay and AChE inhibitory activity by Ellman’s colorimetric method. Results: Our data showed that the total phenolic content of EtOAc fraction was highest equivalents to 35.2±1.4 mg quercetin/g of fraction. Our data also demonstrated that EtOAc fraction had the strongest antioxidant activity with IC 50 was 8.89±1.37 µg/mL and AChE inhibitory activity with an IC 50 value of 22.85±2.37 μg/mL in a dose-dependent manner, followed by BuOH fraction and the n-hexane fraction is the weakest. Detailed kinetic analysis indicated that EtOAc fraction was mixed inhibition type with Ki (representing the affinity of the enzyme and inhibitor) was 30.61±1.43 µg/mL. Conclusions: Our results suggest that the EtOAc fraction of Z. officinale may be a promising source of AChE inhibitors for Alzheimer’s disease.Keywords
This publication has 23 references indexed in Scilit:
- Antioxidant Activity and Phytochemical Contents of Some Selected Nigerian Fruits and VegetablesAmerican Journal of Chemistry, 2012
- Natural products as a source of Alzheimer's drug leadsNatural Product Reports, 2010
- Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older AdultsJournal of the American Geriatrics Society, 2008
- Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's diseaseNucleic Acids Research, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Ginger Extract Inhibits β-Amyloid Peptide–Induced Cytokine and Chemokine Expression in Cultured THP-1 MonocytesThe Journal of Alternative and Complementary Medicine, 2004
- Antioxidant strategies for Alzheimer's diseaseProceedings of the Nutrition Society, 2002
- Screening of Plant Extracts for Antioxidant Activity: a Comparative Study on Three Testing MethodsPhytochemical Analysis, 2002
- Oxidative stress in Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- The Cholinergic Hypothesis: A Historical Overview, Current Perspective, and Future DirectionsAnnals of the New York Academy of Sciences, 1985